2013
DOI: 10.2337/db12-1825
|View full text |Cite
|
Sign up to set email alerts
|

Positive Regulation of Insulin Signaling by Neuraminidase 1

Abstract: Neuraminidases (sialidases) catalyze the removal of sialic acid residues from sialylated glycoconjugates. We now report that mammalian neuraminidase 1 (Neu1), in addition to its catabolic function in lysosomes, is transported to the cell surface where it is involved in the regulation of insulin signaling. Insulin binding to its receptor rapidly induces interaction of the receptor with Neu1, which hydrolyzes sialic acid residues in the glycan chains of the receptor and, consequently, induces its activation. Cel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
67
0
4

Year Published

2013
2013
2017
2017

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 79 publications
(89 citation statements)
references
References 49 publications
2
67
0
4
Order By: Relevance
“…This effect could be explained by the activation of subunit Neu-1, which is a sialic acid hydrolase that specifically clips off terminally located sialic acid on protein surfaces. Our findings support the recent work of Dridi et al (45), who demonstrated that Neu-1 can interact and desialylate IR. Surprisingly, they showed that the interaction is insulin-dependent and upregulates IR signaling.…”
Section: Discussionsupporting
confidence: 93%
“…This effect could be explained by the activation of subunit Neu-1, which is a sialic acid hydrolase that specifically clips off terminally located sialic acid on protein surfaces. Our findings support the recent work of Dridi et al (45), who demonstrated that Neu-1 can interact and desialylate IR. Surprisingly, they showed that the interaction is insulin-dependent and upregulates IR signaling.…”
Section: Discussionsupporting
confidence: 93%
“…In this respect, a compelling observation was that ASMCs exposed to therapeutic concentrations of insulin have de novo formation of elastic fibers, independently of their rate of proliferation. These results were confirmed in fibroblasts from patients with sialidosis, which appear to proliferate faster, respond more strongly to recombinant growth factors than normal fibroblasts, and have impaired insulin-induced phosphorylation of downstream signaling proteins [68, 59]. The latter observation suggests an interesting link between NEU1/EBP-dependent elastogenesis and vascular pathologies associated with diabetes, many of which are linked to elastic fiber disease [69].…”
Section: The Lmc and Its Components In Tissue And Cell Homeostasismentioning
confidence: 84%
“…Indeed, treatment of ASMCs with an exogenous sialidase was shown to abolish the mitogenic responses to growth factors, such as PDGF-BB and IGF-2, through removal of the sialic acids from their respective cognate receptors PDGF-R and IGF-1R [59]. Similarly, in rat skeletal L6 myoblasts alterations of the sialic acid content of the insulin receptor (IR) by mouse-derived Neu1 or C. perfringens sialidase were shown to modulate the proliferative capacity of these cells in response to insulin signaling [67, 68]. In this respect, a compelling observation was that ASMCs exposed to therapeutic concentrations of insulin have de novo formation of elastic fibers, independently of their rate of proliferation.…”
Section: The Lmc and Its Components In Tissue And Cell Homeostasismentioning
confidence: 99%
“…At the plasma membrane, NEU1 has been shown to be required for signal transduction and elastogenesis through the elastin receptor complex91011 and to be involved in the modulation of insulin receptor signaling1213, regulation of integrin beta 414, TLR415, Trk A16, PDGF-BB and IGF receptors17, EGF and MUC1 receptors18 and more recently CD3119. Consequently, NEU1 now emerges not only as a catabolic enzyme but also as a key actor involved in cell signaling regulation20.…”
mentioning
confidence: 99%